Canada markets closed
  • S&P/TSX

    20,220.49
    -163.28 (-0.80%)
     
  • S&P 500

    3,963.94
    -62.18 (-1.54%)
     
  • DOW

    33,849.46
    -497.57 (-1.45%)
     
  • CAD/USD

    0.7446
    +0.0033 (+0.45%)
     
  • CRUDE OIL

    78.63
    +1.39 (+1.80%)
     
  • BTC-CAD

    22,086.80
    +206.63 (+0.94%)
     
  • CMC Crypto 200

    387.45
    +7.16 (+1.88%)
     
  • GOLD FUTURES

    1,751.60
    +11.30 (+0.65%)
     
  • RUSSELL 2000

    1,830.96
    -38.23 (-2.05%)
     
  • 10-Yr Bond

    3.7030
    +0.0120 (+0.33%)
     
  • NASDAQ futures

    11,668.25
    +52.00 (+0.45%)
     
  • VOLATILITY

    22.21
    +1.71 (+8.34%)
     
  • FTSE

    7,474.02
    -12.65 (-0.17%)
     
  • NIKKEI 225

    28,036.44
    -126.39 (-0.45%)
     
  • CAD/EUR

    0.7164
    +0.0001 (+0.01%)
     

2 No-Brainer Stocks to Buy Right Now for Less Than $15

2 No-Brainer Stocks to Buy Right Now for Less Than $15

If so, it was probably for something like Berkshire Hathaway (NYSE: BRK.A), with an eye-popping price of $419,020 per share. Thankfully, there are much cheaper companies to buy, and some of them might even grow a bit faster than Warren Buffett's business. With its shares trading for around $13, having gained 139% in the past 12 months, Catalyst Pharmaceuticals (NASDAQ: CPRX) is a little-known biotech stock that's positioned to keep paying off for investors thanks to its progress in treating a rare neuromuscular disease called Lambert-Eaton myasthenic syndrome (LEMS).